InvestorsHub on MSN
Stryker announces $400 million investment in CMR Surgical with option for full acquisition
Stryker (NYSE:SYK) has announced a strategic partnership with UK-based medical robotics company CMR Surgical, including an ...
Strategic alliance combines CMR Surgical’s established platform and robotics expertise with Stryker’s scale, customer relationships and commercial reach to accelerate growth of the Versius Surgical ...
Stryker, which has been looking to get into the soft tissue robotics market for years, is now positioned to compete with new entrants Johnson & Johnson and Medtronic.
Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global medical technology company, today announces its second-generation surgical robotic platform, Versius ...
CMR Surgical said its Versius system has already completed more than 26,000 keyhole procedures worldwide, as it now gears up to bring the laparoscopic robot to the U.S. (CMR Surgical) CMR Surgical ...
Add Yahoo as a preferred source to see more of our stories on Google. CMR plans to begin US commercial activities for its Versius robots in 2026. Image credit: T. Schneider via Shutterstock.com. CMR ...
Multinational US medical technologies company Stryker has allocated approximately $400million into a strategic alliance with ...
CMR Surgical (CMR or ‘the Company’), a global surgical robotics business, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Versius Surgical ...
CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the ...
Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical interest received from US surgeons nationwide for the system CMR Surgical, a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results